nodes	percent_of_prediction	percent_of_DWPC	metapath
Aciclovir—Entecavir—Cladribine—hematologic cancer	0.258	1	CrCrCtD
Aciclovir—SLC22A1—hematologic cancer	0.224	1	CbGaD
Aciclovir—SLC47A2—Mitoxantrone—hematologic cancer	0.13	0.383	CbGbCtD
Aciclovir—SLC47A1—Imatinib—hematologic cancer	0.0678	0.2	CbGbCtD
Aciclovir—SLC47A1—Mitoxantrone—hematologic cancer	0.0538	0.159	CbGbCtD
Aciclovir—SLC22A1—Cytarabine—hematologic cancer	0.021	0.062	CbGbCtD
Aciclovir—SLC22A1—Cladribine—hematologic cancer	0.0198	0.0586	CbGbCtD
Aciclovir—SLC22A1—Imatinib—hematologic cancer	0.0182	0.0539	CbGbCtD
Aciclovir—SLC22A8—Mercaptopurine—hematologic cancer	0.0182	0.0538	CbGbCtD
Aciclovir—SLC22A8—Methotrexate—hematologic cancer	0.00595	0.0176	CbGbCtD
Aciclovir—SLC22A6—Methotrexate—hematologic cancer	0.00414	0.0122	CbGbCtD
Aciclovir—SLC10A2—hematopoietic system—hematologic cancer	0.0018	0.266	CbGeAlD
Aciclovir—SLC10A2—blood—hematologic cancer	0.00119	0.176	CbGeAlD
Aciclovir—SLC47A1—hematopoietic system—hematologic cancer	0.000655	0.0966	CbGeAlD
Aciclovir—Ganciclovir—SLC22A1—hematologic cancer	0.000623	1	CrCbGaD
Aciclovir—SLC22A8—hematopoietic system—hematologic cancer	0.000502	0.0741	CbGeAlD
Aciclovir—SLC47A1—gonad—hematologic cancer	0.000498	0.0735	CbGeAlD
Aciclovir—SLC47A1—blood—hematologic cancer	0.000434	0.064	CbGeAlD
Aciclovir—SLC47A1—lung—hematologic cancer	0.00038	0.0561	CbGeAlD
Aciclovir—SLC22A1—blood—hematologic cancer	0.000362	0.0534	CbGeAlD
Aciclovir—SLC47A1—testis—hematologic cancer	0.000359	0.053	CbGeAlD
Aciclovir—SLC22A8—blood—hematologic cancer	0.000333	0.0491	CbGeAlD
Aciclovir—SLC47A1—lymph node—hematologic cancer	0.00026	0.0384	CbGeAlD
Aciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	6.7e-05	0.00348	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	6.63e-05	0.00345	CbGpPWpGaD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	6.61e-05	0.00343	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	6.61e-05	0.00343	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	6.61e-05	0.00343	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—SGK1—hematologic cancer	6.61e-05	0.00343	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	6.46e-05	0.00336	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	6.3e-05	0.00328	CbGpPWpGaD
Aciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	6.27e-05	0.00326	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—B3GAT1—hematologic cancer	6.22e-05	0.00323	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ASNS—hematologic cancer	6.22e-05	0.00323	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—DCK—hematologic cancer	6.22e-05	0.00323	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	6.08e-05	0.00316	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—NUP98—hematologic cancer	5.95e-05	0.00309	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	5.95e-05	0.00309	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—HDC—hematologic cancer	5.89e-05	0.00306	CbGpPWpGaD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—TFRC—hematologic cancer	5.89e-05	0.00306	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	5.78e-05	0.003	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—NUP214—hematologic cancer	5.74e-05	0.00298	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	5.62e-05	0.00292	CbGpPWpGaD
Aciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	5.59e-05	0.00291	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	5.49e-05	0.00285	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—AQP9—hematologic cancer	5.42e-05	0.00282	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CDA—hematologic cancer	5.39e-05	0.0028	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	5.22e-05	0.00271	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PC—hematologic cancer	5.19e-05	0.0027	CbGpPWpGaD
Aciclovir—SLC47A2—SLC-mediated transmembrane transport—ALB—hematologic cancer	5.08e-05	0.00264	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—FXYD6—hematologic cancer	5.04e-05	0.00262	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GBA—hematologic cancer	5.01e-05	0.0026	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—SLC35B2—hematologic cancer	5.01e-05	0.0026	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—TFRC—hematologic cancer	5.01e-05	0.0026	CbGpPWpGaD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.94e-05	0.00257	CbGpPWpGaD
Aciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	4.87e-05	0.00253	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	4.78e-05	0.00248	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—MTAP—hematologic cancer	4.58e-05	0.00238	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—AQP9—hematologic cancer	4.52e-05	0.00235	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—NUP98—hematologic cancer	4.51e-05	0.00234	CbGpPWpGaD
Aciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	4.43e-05	0.0023	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	4.38e-05	0.00227	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	4.35e-05	0.00226	CbGpPWpGaD
Aciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	4.34e-05	0.00226	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	4.26e-05	0.00221	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—FXYD6—hematologic cancer	4.21e-05	0.00219	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.2e-05	0.00218	CbGpPWpGaD
Aciclovir—SLC22A8—SLC-mediated transmembrane transport—NUP98—hematologic cancer	4.18e-05	0.00217	CbGpPWpGaD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	4.12e-05	0.00214	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—S100A10—hematologic cancer	4.11e-05	0.00214	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—FHL2—hematologic cancer	4.08e-05	0.00212	CbGpPWpGaD
Aciclovir—SLC22A8—SLC-mediated transmembrane transport—NUP214—hematologic cancer	4.03e-05	0.00209	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—AGRN—hematologic cancer	4.01e-05	0.00208	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	3.82e-05	0.00198	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—HMMR—hematologic cancer	3.8e-05	0.00197	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—IDH2—hematologic cancer	3.8e-05	0.00197	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	3.8e-05	0.00197	CbGpPWpGaD
Aciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	3.7e-05	0.00192	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	3.59e-05	0.00187	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.58e-05	0.00186	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ARNTL—hematologic cancer	3.57e-05	0.00186	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—AQP9—hematologic cancer	3.52e-05	0.00183	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.51e-05	0.00182	CbGpPWpGaD
Aciclovir—SLC22A6—SLC-mediated transmembrane transport—NUP98—hematologic cancer	3.49e-05	0.00181	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CA9—hematologic cancer	3.47e-05	0.0018	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ACP5—hematologic cancer	3.47e-05	0.0018	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—S100A10—hematologic cancer	3.43e-05	0.00178	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—NCOR2—hematologic cancer	3.43e-05	0.00178	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	3.4e-05	0.00177	CbGpPWpGaD
Aciclovir—SLC22A6—SLC-mediated transmembrane transport—NUP214—hematologic cancer	3.36e-05	0.00175	CbGpPWpGaD
Aciclovir—SLC47A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	3.27e-05	0.0017	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	3.27e-05	0.0017	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—IDH1—hematologic cancer	3.27e-05	0.0017	CbGpPWpGaD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—ADCY7—hematologic cancer	3.25e-05	0.00169	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ABCC3—hematologic cancer	3.23e-05	0.00168	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GSTO1—hematologic cancer	3.23e-05	0.00168	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—TXN—hematologic cancer	3.23e-05	0.00168	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	3.19e-05	0.00166	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.19e-05	0.00166	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—SPHK1—hematologic cancer	3.16e-05	0.00164	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—SGK1—hematologic cancer	3.11e-05	0.00162	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—ANXA2—hematologic cancer	3.11e-05	0.00162	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—ATP4A—hematologic cancer	3.11e-05	0.00162	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—UGT1A1—hematologic cancer	3.04e-05	0.00158	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	3e-05	0.00156	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—SLC22A1—hematologic cancer	2.95e-05	0.00153	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CRABP1—hematologic cancer	2.95e-05	0.00153	CbGpPWpGaD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—CAMK2D—hematologic cancer	2.89e-05	0.0015	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ALOX5—hematologic cancer	2.88e-05	0.0015	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	2.84e-05	0.00148	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	2.8e-05	0.00146	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—NUP98—hematologic cancer	2.79e-05	0.00145	CbGpPWpGaD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.76e-05	0.00143	CbGpPWpGaD
Aciclovir—SLC22A1—SLC-mediated transmembrane transport—NUP98—hematologic cancer	2.71e-05	0.00141	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ADCY7—hematologic cancer	2.71e-05	0.00141	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—NCOA3—hematologic cancer	2.71e-05	0.00141	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—NUP214—hematologic cancer	2.69e-05	0.0014	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—S100A10—hematologic cancer	2.66e-05	0.00138	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.66e-05	0.00138	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.66e-05	0.00138	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—MTR—hematologic cancer	2.63e-05	0.00137	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ABCG2—hematologic cancer	2.63e-05	0.00137	CbGpPWpGaD
Aciclovir—SLC22A1—SLC-mediated transmembrane transport—NUP214—hematologic cancer	2.61e-05	0.00136	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—ATP4A—hematologic cancer	2.6e-05	0.00135	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—ANXA2—hematologic cancer	2.6e-05	0.00135	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SGK1—hematologic cancer	2.6e-05	0.00135	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ENO2—hematologic cancer	2.58e-05	0.00134	CbGpPWpGaD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—ALB—hematologic cancer	2.58e-05	0.00134	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GSTT1—hematologic cancer	2.5e-05	0.0013	CbGpPWpGaD
Aciclovir—SLC22A1—Neuronal System—ADCY7—hematologic cancer	2.49e-05	0.00129	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	2.48e-05	0.00129	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.47e-05	0.00128	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—ABCC3—hematologic cancer	2.46e-05	0.00128	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—SDC1—hematologic cancer	2.45e-05	0.00127	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.34e-05	0.00122	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	2.34e-05	0.00122	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.34e-05	0.00121	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	2.33e-05	0.00121	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.31e-05	0.0012	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	2.25e-05	0.00117	CbGpPWpGaD
Aciclovir—SLC22A1—Neuronal System—CAMK2D—hematologic cancer	2.21e-05	0.00115	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	2.21e-05	0.00115	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.21e-05	0.00115	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—ALB—hematologic cancer	2.19e-05	0.00114	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—NUP98—hematologic cancer	2.12e-05	0.0011	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CD44—hematologic cancer	2.08e-05	0.00108	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—NQO1—hematologic cancer	2.08e-05	0.00108	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—ADCY7—hematologic cancer	2.06e-05	0.00107	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—ABCC3—hematologic cancer	2.05e-05	0.00107	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—NUP214—hematologic cancer	2.05e-05	0.00106	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.04e-05	0.00106	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	2.02e-05	0.00105	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	2.02e-05	0.00105	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—SGK1—hematologic cancer	2.02e-05	0.00105	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—ABCG2—hematologic cancer	2.01e-05	0.00104	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CYCS—hematologic cancer	1.97e-05	0.00102	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—HSP90AA1—hematologic cancer	1.96e-05	0.00102	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.88e-05	0.000976	CbGpPWpGaD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—PRKCG—hematologic cancer	1.83e-05	0.000949	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.82e-05	0.000945	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GMPS—hematologic cancer	1.8e-05	0.000936	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—FTCD—hematologic cancer	1.8e-05	0.000936	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PHYH—hematologic cancer	1.8e-05	0.000936	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.79e-05	0.000929	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.78e-05	0.000923	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.77e-05	0.000921	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.76e-05	0.000915	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GSTP1—hematologic cancer	1.74e-05	0.000902	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.72e-05	0.000895	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.71e-05	0.000888	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.68e-05	0.000872	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.67e-05	0.00087	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.66e-05	0.000864	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—SMPD3—hematologic cancer	1.65e-05	0.000856	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ABCB1—hematologic cancer	1.64e-05	0.000854	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.6e-05	0.000829	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—NCOR1—hematologic cancer	1.59e-05	0.000829	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GSTM1—hematologic cancer	1.59e-05	0.000829	CbGpPWpGaD
Aciclovir—SLC22A8—SLC-mediated transmembrane transport—ALB—hematologic cancer	1.54e-05	0.000801	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.5e-05	0.00078	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.49e-05	0.000776	CbGpPWpGaD
Aciclovir—Immune system disorder—Epirubicin—hematologic cancer	1.48e-05	9.74e-05	CcSEcCtD
Aciclovir—Mediastinal disorder—Epirubicin—hematologic cancer	1.48e-05	9.72e-05	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.48e-05	9.71e-05	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.48e-05	9.71e-05	CcSEcCtD
Aciclovir—Fatigue—Betamethasone—hematologic cancer	1.48e-05	9.7e-05	CcSEcCtD
Aciclovir—Fatigue—Dexamethasone—hematologic cancer	1.48e-05	9.7e-05	CcSEcCtD
Aciclovir—Chills—Epirubicin—hematologic cancer	1.47e-05	9.68e-05	CcSEcCtD
Aciclovir—Pruritus—Etoposide—hematologic cancer	1.47e-05	9.67e-05	CcSEcCtD
Aciclovir—Pain—Betamethasone—hematologic cancer	1.47e-05	9.62e-05	CcSEcCtD
Aciclovir—Pain—Dexamethasone—hematologic cancer	1.47e-05	9.62e-05	CcSEcCtD
Aciclovir—Nervous system disorder—Prednisone—hematologic cancer	1.46e-05	9.61e-05	CcSEcCtD
Aciclovir—Tachycardia—Prednisone—hematologic cancer	1.46e-05	9.56e-05	CcSEcCtD
Aciclovir—Alopecia—Epirubicin—hematologic cancer	1.45e-05	9.53e-05	CcSEcCtD
Aciclovir—Skin disorder—Prednisone—hematologic cancer	1.45e-05	9.51e-05	CcSEcCtD
Aciclovir—Nausea—Gemcitabine—hematologic cancer	1.45e-05	9.51e-05	CcSEcCtD
Aciclovir—Vomiting—Cisplatin—hematologic cancer	1.45e-05	9.49e-05	CcSEcCtD
Aciclovir—Hyperhidrosis—Prednisone—hematologic cancer	1.44e-05	9.47e-05	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—DCK—hematologic cancer	1.44e-05	0.000748	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—B3GAT1—hematologic cancer	1.44e-05	0.000748	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ASNS—hematologic cancer	1.44e-05	0.000748	CbGpPWpGaD
Aciclovir—Erythema multiforme—Doxorubicin—hematologic cancer	1.44e-05	9.43e-05	CcSEcCtD
Aciclovir—Rash—Cisplatin—hematologic cancer	1.43e-05	9.41e-05	CcSEcCtD
Aciclovir—Dermatitis—Cisplatin—hematologic cancer	1.43e-05	9.4e-05	CcSEcCtD
Aciclovir—Erythema—Epirubicin—hematologic cancer	1.43e-05	9.39e-05	CcSEcCtD
Aciclovir—Diarrhoea—Etoposide—hematologic cancer	1.43e-05	9.35e-05	CcSEcCtD
Aciclovir—Anorexia—Prednisone—hematologic cancer	1.42e-05	9.34e-05	CcSEcCtD
Aciclovir—Eye disorder—Doxorubicin—hematologic cancer	1.42e-05	9.32e-05	CcSEcCtD
Aciclovir—Ill-defined disorder—Methotrexate—hematologic cancer	1.42e-05	9.31e-05	CcSEcCtD
Aciclovir—Anaemia—Methotrexate—hematologic cancer	1.41e-05	9.27e-05	CcSEcCtD
Aciclovir—Feeling abnormal—Betamethasone—hematologic cancer	1.41e-05	9.27e-05	CcSEcCtD
Aciclovir—Feeling abnormal—Dexamethasone—hematologic cancer	1.41e-05	9.27e-05	CcSEcCtD
Aciclovir—Flatulence—Epirubicin—hematologic cancer	1.41e-05	9.25e-05	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—MTHFR—hematologic cancer	1.41e-05	0.000732	CbGpPWpGaD
Aciclovir—Gastrointestinal pain—Betamethasone—hematologic cancer	1.4e-05	9.2e-05	CcSEcCtD
Aciclovir—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.4e-05	9.2e-05	CcSEcCtD
Aciclovir—Dysgeusia—Epirubicin—hematologic cancer	1.4e-05	9.19e-05	CcSEcCtD
Aciclovir—SLC22A1—Neuronal System—PRKCG—hematologic cancer	1.4e-05	0.000727	CbGpPWpGaD
Aciclovir—Hypersensitivity—Triamcinolone—hematologic cancer	1.39e-05	9.13e-05	CcSEcCtD
Aciclovir—Malaise—Methotrexate—hematologic cancer	1.38e-05	9.05e-05	CcSEcCtD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.38e-05	0.000716	CbGpPWpGaD
Aciclovir—Dizziness—Etoposide—hematologic cancer	1.38e-05	9.04e-05	CcSEcCtD
Aciclovir—Muscle spasms—Epirubicin—hematologic cancer	1.38e-05	9.03e-05	CcSEcCtD
Aciclovir—Immune system disorder—Doxorubicin—hematologic cancer	1.37e-05	9.01e-05	CcSEcCtD
Aciclovir—Vertigo—Methotrexate—hematologic cancer	1.37e-05	9.01e-05	CcSEcCtD
Aciclovir—Mediastinal disorder—Doxorubicin—hematologic cancer	1.37e-05	8.99e-05	CcSEcCtD
Aciclovir—Leukopenia—Methotrexate—hematologic cancer	1.37e-05	8.98e-05	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—HDC—hematologic cancer	1.36e-05	0.000709	CbGpPWpGaD
Aciclovir—Chills—Doxorubicin—hematologic cancer	1.36e-05	8.95e-05	CcSEcCtD
Aciclovir—Urticaria—Dexamethasone—hematologic cancer	1.36e-05	8.94e-05	CcSEcCtD
Aciclovir—Urticaria—Betamethasone—hematologic cancer	1.36e-05	8.94e-05	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.36e-05	8.92e-05	CcSEcCtD
Aciclovir—Dizziness—Prednisolone—hematologic cancer	1.36e-05	8.91e-05	CcSEcCtD
Aciclovir—Asthenia—Triamcinolone—hematologic cancer	1.36e-05	8.89e-05	CcSEcCtD
Aciclovir—Body temperature increased—Dexamethasone—hematologic cancer	1.36e-05	8.89e-05	CcSEcCtD
Aciclovir—Body temperature increased—Betamethasone—hematologic cancer	1.36e-05	8.89e-05	CcSEcCtD
Aciclovir—Abdominal pain—Dexamethasone—hematologic cancer	1.36e-05	8.89e-05	CcSEcCtD
Aciclovir—Abdominal pain—Betamethasone—hematologic cancer	1.36e-05	8.89e-05	CcSEcCtD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—CREB1—hematologic cancer	1.35e-05	0.000703	CbGpPWpGaD
Aciclovir—Nausea—Cisplatin—hematologic cancer	1.35e-05	8.86e-05	CcSEcCtD
Aciclovir—Insomnia—Prednisone—hematologic cancer	1.35e-05	8.86e-05	CcSEcCtD
Aciclovir—Alopecia—Doxorubicin—hematologic cancer	1.34e-05	8.82e-05	CcSEcCtD
Aciclovir—Paraesthesia—Prednisone—hematologic cancer	1.34e-05	8.8e-05	CcSEcCtD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.34e-05	0.000695	CbGpPWpGaD
Aciclovir—Pruritus—Triamcinolone—hematologic cancer	1.34e-05	8.77e-05	CcSEcCtD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—BRAF—hematologic cancer	1.34e-05	0.000694	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.33e-05	0.00069	CbGpPWpGaD
Aciclovir—Ill-defined disorder—Epirubicin—hematologic cancer	1.33e-05	8.71e-05	CcSEcCtD
Aciclovir—Convulsion—Methotrexate—hematologic cancer	1.32e-05	8.69e-05	CcSEcCtD
Aciclovir—Vomiting—Etoposide—hematologic cancer	1.32e-05	8.69e-05	CcSEcCtD
Aciclovir—Erythema—Doxorubicin—hematologic cancer	1.32e-05	8.69e-05	CcSEcCtD
Aciclovir—Anaemia—Epirubicin—hematologic cancer	1.32e-05	8.68e-05	CcSEcCtD
Aciclovir—Agitation—Epirubicin—hematologic cancer	1.31e-05	8.63e-05	CcSEcCtD
Aciclovir—Dyspepsia—Prednisone—hematologic cancer	1.31e-05	8.62e-05	CcSEcCtD
Aciclovir—Rash—Etoposide—hematologic cancer	1.31e-05	8.62e-05	CcSEcCtD
Aciclovir—Dermatitis—Etoposide—hematologic cancer	1.31e-05	8.61e-05	CcSEcCtD
Aciclovir—Headache—Etoposide—hematologic cancer	1.3e-05	8.56e-05	CcSEcCtD
Aciclovir—Flatulence—Doxorubicin—hematologic cancer	1.3e-05	8.56e-05	CcSEcCtD
Aciclovir—Chest pain—Methotrexate—hematologic cancer	1.3e-05	8.54e-05	CcSEcCtD
Aciclovir—Arthralgia—Methotrexate—hematologic cancer	1.3e-05	8.54e-05	CcSEcCtD
Aciclovir—Myalgia—Methotrexate—hematologic cancer	1.3e-05	8.54e-05	CcSEcCtD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.3e-05	0.000676	CbGpPWpGaD
Aciclovir—Decreased appetite—Prednisone—hematologic cancer	1.3e-05	8.52e-05	CcSEcCtD
Aciclovir—Dysgeusia—Doxorubicin—hematologic cancer	1.3e-05	8.51e-05	CcSEcCtD
Aciclovir—Rash—Prednisolone—hematologic cancer	1.3e-05	8.5e-05	CcSEcCtD
Aciclovir—Dermatitis—Prednisolone—hematologic cancer	1.29e-05	8.49e-05	CcSEcCtD
Aciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.29e-05	8.48e-05	CcSEcCtD
Aciclovir—Malaise—Epirubicin—hematologic cancer	1.29e-05	8.47e-05	CcSEcCtD
Aciclovir—Fatigue—Prednisone—hematologic cancer	1.29e-05	8.45e-05	CcSEcCtD
Aciclovir—Headache—Prednisolone—hematologic cancer	1.29e-05	8.44e-05	CcSEcCtD
Aciclovir—SLC22A6—SLC-mediated transmembrane transport—ALB—hematologic cancer	1.29e-05	0.000669	CbGpPWpGaD
Aciclovir—Discomfort—Methotrexate—hematologic cancer	1.29e-05	8.44e-05	CcSEcCtD
Aciclovir—Vertigo—Epirubicin—hematologic cancer	1.29e-05	8.43e-05	CcSEcCtD
Aciclovir—Leukopenia—Epirubicin—hematologic cancer	1.28e-05	8.4e-05	CcSEcCtD
Aciclovir—Constipation—Prednisone—hematologic cancer	1.28e-05	8.38e-05	CcSEcCtD
Aciclovir—Muscle spasms—Doxorubicin—hematologic cancer	1.27e-05	8.35e-05	CcSEcCtD
Aciclovir—Palpitations—Epirubicin—hematologic cancer	1.26e-05	8.3e-05	CcSEcCtD
Aciclovir—Confusional state—Methotrexate—hematologic cancer	1.26e-05	8.25e-05	CcSEcCtD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.25e-05	0.000651	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.25e-05	0.000651	CbGpPWpGaD
Aciclovir—Dizziness—Triamcinolone—hematologic cancer	1.25e-05	8.2e-05	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—CDA—hematologic cancer	1.25e-05	0.000649	CbGpPWpGaD
Aciclovir—Anaphylactic shock—Methotrexate—hematologic cancer	1.25e-05	8.19e-05	CcSEcCtD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.24e-05	0.000645	CbGpPWpGaD
Aciclovir—Convulsion—Epirubicin—hematologic cancer	1.24e-05	8.13e-05	CcSEcCtD
Aciclovir—Nausea—Etoposide—hematologic cancer	1.24e-05	8.12e-05	CcSEcCtD
Aciclovir—Hypertension—Epirubicin—hematologic cancer	1.24e-05	8.1e-05	CcSEcCtD
Aciclovir—Feeling abnormal—Prednisone—hematologic cancer	1.23e-05	8.07e-05	CcSEcCtD
Aciclovir—Asthenia—Dexamethasone—hematologic cancer	1.23e-05	8.07e-05	CcSEcCtD
Aciclovir—Asthenia—Betamethasone—hematologic cancer	1.23e-05	8.07e-05	CcSEcCtD
Aciclovir—Ill-defined disorder—Doxorubicin—hematologic cancer	1.23e-05	8.06e-05	CcSEcCtD
Aciclovir—Nervous system disorder—Methotrexate—hematologic cancer	1.22e-05	8.03e-05	CcSEcCtD
Aciclovir—Anaemia—Doxorubicin—hematologic cancer	1.22e-05	8.03e-05	CcSEcCtD
Aciclovir—Thrombocytopenia—Methotrexate—hematologic cancer	1.22e-05	8.02e-05	CcSEcCtD
Aciclovir—Gastrointestinal pain—Prednisone—hematologic cancer	1.22e-05	8.01e-05	CcSEcCtD
Aciclovir—Nausea—Prednisolone—hematologic cancer	1.22e-05	8.01e-05	CcSEcCtD
Aciclovir—Chest pain—Epirubicin—hematologic cancer	1.22e-05	7.99e-05	CcSEcCtD
Aciclovir—Myalgia—Epirubicin—hematologic cancer	1.22e-05	7.99e-05	CcSEcCtD
Aciclovir—Arthralgia—Epirubicin—hematologic cancer	1.22e-05	7.99e-05	CcSEcCtD
Aciclovir—Agitation—Doxorubicin—hematologic cancer	1.22e-05	7.98e-05	CcSEcCtD
Aciclovir—Pruritus—Dexamethasone—hematologic cancer	1.21e-05	7.96e-05	CcSEcCtD
Aciclovir—Pruritus—Betamethasone—hematologic cancer	1.21e-05	7.96e-05	CcSEcCtD
Aciclovir—Skin disorder—Methotrexate—hematologic cancer	1.21e-05	7.95e-05	CcSEcCtD
Aciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.21e-05	7.94e-05	CcSEcCtD
Aciclovir—Hyperhidrosis—Methotrexate—hematologic cancer	1.21e-05	7.91e-05	CcSEcCtD
Aciclovir—Discomfort—Epirubicin—hematologic cancer	1.2e-05	7.9e-05	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—PC—hematologic cancer	1.2e-05	0.000624	CbGpPWpGaD
Aciclovir—Vomiting—Triamcinolone—hematologic cancer	1.2e-05	7.88e-05	CcSEcCtD
Aciclovir—Malaise—Doxorubicin—hematologic cancer	1.19e-05	7.83e-05	CcSEcCtD
Aciclovir—Rash—Triamcinolone—hematologic cancer	1.19e-05	7.82e-05	CcSEcCtD
Aciclovir—Dermatitis—Triamcinolone—hematologic cancer	1.19e-05	7.81e-05	CcSEcCtD
Aciclovir—Vertigo—Doxorubicin—hematologic cancer	1.19e-05	7.8e-05	CcSEcCtD
Aciclovir—Anorexia—Methotrexate—hematologic cancer	1.19e-05	7.8e-05	CcSEcCtD
Aciclovir—Urticaria—Prednisone—hematologic cancer	1.19e-05	7.78e-05	CcSEcCtD
Aciclovir—Leukopenia—Doxorubicin—hematologic cancer	1.18e-05	7.77e-05	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—PIK3CG—hematologic cancer	1.18e-05	0.000615	CbGpPWpGaD
Aciclovir—Headache—Triamcinolone—hematologic cancer	1.18e-05	7.77e-05	CcSEcCtD
Aciclovir—Abdominal pain—Prednisone—hematologic cancer	1.18e-05	7.74e-05	CcSEcCtD
Aciclovir—Body temperature increased—Prednisone—hematologic cancer	1.18e-05	7.74e-05	CcSEcCtD
Aciclovir—Confusional state—Epirubicin—hematologic cancer	1.18e-05	7.72e-05	CcSEcCtD
Aciclovir—Diarrhoea—Dexamethasone—hematologic cancer	1.17e-05	7.7e-05	CcSEcCtD
Aciclovir—Diarrhoea—Betamethasone—hematologic cancer	1.17e-05	7.7e-05	CcSEcCtD
Aciclovir—Palpitations—Doxorubicin—hematologic cancer	1.17e-05	7.68e-05	CcSEcCtD
Aciclovir—Oedema—Epirubicin—hematologic cancer	1.17e-05	7.66e-05	CcSEcCtD
Aciclovir—Anaphylactic shock—Epirubicin—hematologic cancer	1.17e-05	7.66e-05	CcSEcCtD
Aciclovir—Hypotension—Methotrexate—hematologic cancer	1.17e-05	7.65e-05	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—SLC35B2—hematologic cancer	1.16e-05	0.000603	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GBA—hematologic cancer	1.16e-05	0.000603	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.16e-05	0.000603	CbGpPWpGaD
Aciclovir—Convulsion—Doxorubicin—hematologic cancer	1.15e-05	7.53e-05	CcSEcCtD
Aciclovir—Nervous system disorder—Epirubicin—hematologic cancer	1.15e-05	7.51e-05	CcSEcCtD
Aciclovir—Thrombocytopenia—Epirubicin—hematologic cancer	1.14e-05	7.5e-05	CcSEcCtD
Aciclovir—Hypertension—Doxorubicin—hematologic cancer	1.14e-05	7.5e-05	CcSEcCtD
Aciclovir—Tachycardia—Epirubicin—hematologic cancer	1.14e-05	7.48e-05	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.14e-05	7.46e-05	CcSEcCtD
Aciclovir—Skin disorder—Epirubicin—hematologic cancer	1.13e-05	7.44e-05	CcSEcCtD
Aciclovir—Dizziness—Dexamethasone—hematologic cancer	1.13e-05	7.44e-05	CcSEcCtD
Aciclovir—Dizziness—Betamethasone—hematologic cancer	1.13e-05	7.44e-05	CcSEcCtD
Aciclovir—Hyperhidrosis—Epirubicin—hematologic cancer	1.13e-05	7.41e-05	CcSEcCtD
Aciclovir—Insomnia—Methotrexate—hematologic cancer	1.13e-05	7.4e-05	CcSEcCtD
Aciclovir—Chest pain—Doxorubicin—hematologic cancer	1.13e-05	7.39e-05	CcSEcCtD
Aciclovir—Myalgia—Doxorubicin—hematologic cancer	1.13e-05	7.39e-05	CcSEcCtD
Aciclovir—Arthralgia—Doxorubicin—hematologic cancer	1.13e-05	7.39e-05	CcSEcCtD
Aciclovir—Nausea—Triamcinolone—hematologic cancer	1.12e-05	7.36e-05	CcSEcCtD
Aciclovir—Paraesthesia—Methotrexate—hematologic cancer	1.12e-05	7.35e-05	CcSEcCtD
Aciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.12e-05	7.34e-05	CcSEcCtD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—MDM2—hematologic cancer	1.12e-05	0.000582	CbGpPWpGaD
Aciclovir—Discomfort—Doxorubicin—hematologic cancer	1.11e-05	7.31e-05	CcSEcCtD
Aciclovir—Anorexia—Epirubicin—hematologic cancer	1.11e-05	7.3e-05	CcSEcCtD
Aciclovir—Dyspnoea—Methotrexate—hematologic cancer	1.11e-05	7.3e-05	CcSEcCtD
Aciclovir—Somnolence—Methotrexate—hematologic cancer	1.11e-05	7.28e-05	CcSEcCtD
Aciclovir—Hypersensitivity—Prednisone—hematologic cancer	1.1e-05	7.22e-05	CcSEcCtD
Aciclovir—Dyspepsia—Methotrexate—hematologic cancer	1.1e-05	7.21e-05	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—CREBBP—hematologic cancer	1.1e-05	0.00057	CbGpPWpGaD
Aciclovir—Hypotension—Epirubicin—hematologic cancer	1.09e-05	7.16e-05	CcSEcCtD
Aciclovir—Vomiting—Betamethasone—hematologic cancer	1.09e-05	7.15e-05	CcSEcCtD
Aciclovir—Vomiting—Dexamethasone—hematologic cancer	1.09e-05	7.15e-05	CcSEcCtD
Aciclovir—Confusional state—Doxorubicin—hematologic cancer	1.09e-05	7.15e-05	CcSEcCtD
Aciclovir—Decreased appetite—Methotrexate—hematologic cancer	1.08e-05	7.12e-05	CcSEcCtD
Aciclovir—Rash—Dexamethasone—hematologic cancer	1.08e-05	7.09e-05	CcSEcCtD
Aciclovir—Rash—Betamethasone—hematologic cancer	1.08e-05	7.09e-05	CcSEcCtD
Aciclovir—Anaphylactic shock—Doxorubicin—hematologic cancer	1.08e-05	7.09e-05	CcSEcCtD
Aciclovir—Oedema—Doxorubicin—hematologic cancer	1.08e-05	7.09e-05	CcSEcCtD
Aciclovir—Dermatitis—Betamethasone—hematologic cancer	1.08e-05	7.09e-05	CcSEcCtD
Aciclovir—Dermatitis—Dexamethasone—hematologic cancer	1.08e-05	7.09e-05	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.08e-05	7.07e-05	CcSEcCtD
Aciclovir—Fatigue—Methotrexate—hematologic cancer	1.08e-05	7.06e-05	CcSEcCtD
Aciclovir—Headache—Dexamethasone—hematologic cancer	1.07e-05	7.05e-05	CcSEcCtD
Aciclovir—Headache—Betamethasone—hematologic cancer	1.07e-05	7.05e-05	CcSEcCtD
Aciclovir—Asthenia—Prednisone—hematologic cancer	1.07e-05	7.03e-05	CcSEcCtD
Aciclovir—Pain—Methotrexate—hematologic cancer	1.07e-05	7e-05	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.06e-05	6.98e-05	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—MTAP—hematologic cancer	1.06e-05	0.000551	CbGpPWpGaD
Aciclovir—Nervous system disorder—Doxorubicin—hematologic cancer	1.06e-05	6.95e-05	CcSEcCtD
Aciclovir—Thrombocytopenia—Doxorubicin—hematologic cancer	1.06e-05	6.94e-05	CcSEcCtD
Aciclovir—Pruritus—Prednisone—hematologic cancer	1.06e-05	6.93e-05	CcSEcCtD
Aciclovir—Insomnia—Epirubicin—hematologic cancer	1.06e-05	6.93e-05	CcSEcCtD
Aciclovir—Tachycardia—Doxorubicin—hematologic cancer	1.05e-05	6.92e-05	CcSEcCtD
Aciclovir—Skin disorder—Doxorubicin—hematologic cancer	1.05e-05	6.89e-05	CcSEcCtD
Aciclovir—Paraesthesia—Epirubicin—hematologic cancer	1.05e-05	6.88e-05	CcSEcCtD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.05e-05	0.000543	CbGpPWpGaD
Aciclovir—Hyperhidrosis—Doxorubicin—hematologic cancer	1.04e-05	6.85e-05	CcSEcCtD
Aciclovir—Dyspnoea—Epirubicin—hematologic cancer	1.04e-05	6.83e-05	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—PIK3CD—hematologic cancer	1.04e-05	0.000541	CbGpPWpGaD
Aciclovir—Somnolence—Epirubicin—hematologic cancer	1.04e-05	6.81e-05	CcSEcCtD
Aciclovir—SLC22A1—Neuronal System—CREB1—hematologic cancer	1.04e-05	0.000539	CbGpPWpGaD
Aciclovir—Anorexia—Doxorubicin—hematologic cancer	1.03e-05	6.76e-05	CcSEcCtD
Aciclovir—Feeling abnormal—Methotrexate—hematologic cancer	1.03e-05	6.75e-05	CcSEcCtD
Aciclovir—Dyspepsia—Epirubicin—hematologic cancer	1.03e-05	6.74e-05	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—ALB—hematologic cancer	1.03e-05	0.000534	CbGpPWpGaD
Aciclovir—SLC22A1—Neuronal System—BRAF—hematologic cancer	1.02e-05	0.000532	CbGpPWpGaD
Aciclovir—Diarrhoea—Prednisone—hematologic cancer	1.02e-05	6.7e-05	CcSEcCtD
Aciclovir—Gastrointestinal pain—Methotrexate—hematologic cancer	1.02e-05	6.69e-05	CcSEcCtD
Aciclovir—Nausea—Dexamethasone—hematologic cancer	1.02e-05	6.68e-05	CcSEcCtD
Aciclovir—Nausea—Betamethasone—hematologic cancer	1.02e-05	6.68e-05	CcSEcCtD
Aciclovir—Decreased appetite—Epirubicin—hematologic cancer	1.02e-05	6.66e-05	CcSEcCtD
Aciclovir—Hypotension—Doxorubicin—hematologic cancer	1.01e-05	6.62e-05	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.01e-05	6.61e-05	CcSEcCtD
Aciclovir—Fatigue—Epirubicin—hematologic cancer	1.01e-05	6.61e-05	CcSEcCtD
Aciclovir—SLC22A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	1e-05	0.00052	CbGpPWpGaD
Aciclovir—Constipation—Epirubicin—hematologic cancer	9.99e-06	6.55e-05	CcSEcCtD
Aciclovir—Pain—Epirubicin—hematologic cancer	9.99e-06	6.55e-05	CcSEcCtD
Aciclovir—Urticaria—Methotrexate—hematologic cancer	9.91e-06	6.5e-05	CcSEcCtD
Aciclovir—Dizziness—Prednisone—hematologic cancer	9.87e-06	6.48e-05	CcSEcCtD
Aciclovir—Abdominal pain—Methotrexate—hematologic cancer	9.86e-06	6.47e-05	CcSEcCtD
Aciclovir—Body temperature increased—Methotrexate—hematologic cancer	9.86e-06	6.47e-05	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	9.84e-06	6.46e-05	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—PIK3R1—hematologic cancer	9.83e-06	0.000511	CbGpPWpGaD
Aciclovir—Insomnia—Doxorubicin—hematologic cancer	9.77e-06	6.41e-05	CcSEcCtD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.73e-06	0.000506	CbGpPWpGaD
Aciclovir—Paraesthesia—Doxorubicin—hematologic cancer	9.7e-06	6.37e-05	CcSEcCtD
Aciclovir—Dyspnoea—Doxorubicin—hematologic cancer	9.63e-06	6.32e-05	CcSEcCtD
Aciclovir—Feeling abnormal—Epirubicin—hematologic cancer	9.62e-06	6.31e-05	CcSEcCtD
Aciclovir—Somnolence—Doxorubicin—hematologic cancer	9.6e-06	6.3e-05	CcSEcCtD
Aciclovir—Gastrointestinal pain—Epirubicin—hematologic cancer	9.55e-06	6.26e-05	CcSEcCtD
Aciclovir—Dyspepsia—Doxorubicin—hematologic cancer	9.51e-06	6.24e-05	CcSEcCtD
Aciclovir—Vomiting—Prednisone—hematologic cancer	9.49e-06	6.23e-05	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—FHL2—hematologic cancer	9.46e-06	0.000491	CbGpPWpGaD
Aciclovir—Rash—Prednisone—hematologic cancer	9.41e-06	6.18e-05	CcSEcCtD
Aciclovir—Dermatitis—Prednisone—hematologic cancer	9.4e-06	6.17e-05	CcSEcCtD
Aciclovir—Decreased appetite—Doxorubicin—hematologic cancer	9.39e-06	6.16e-05	CcSEcCtD
Aciclovir—Headache—Prednisone—hematologic cancer	9.35e-06	6.14e-05	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Doxorubicin—hematologic cancer	9.33e-06	6.12e-05	CcSEcCtD
Aciclovir—Fatigue—Doxorubicin—hematologic cancer	9.31e-06	6.11e-05	CcSEcCtD
Aciclovir—Urticaria—Epirubicin—hematologic cancer	9.28e-06	6.09e-05	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—AGRN—hematologic cancer	9.28e-06	0.000482	CbGpPWpGaD
Aciclovir—Constipation—Doxorubicin—hematologic cancer	9.24e-06	6.06e-05	CcSEcCtD
Aciclovir—Pain—Doxorubicin—hematologic cancer	9.24e-06	6.06e-05	CcSEcCtD
Aciclovir—Abdominal pain—Epirubicin—hematologic cancer	9.23e-06	6.06e-05	CcSEcCtD
Aciclovir—Body temperature increased—Epirubicin—hematologic cancer	9.23e-06	6.06e-05	CcSEcCtD
Aciclovir—Hypersensitivity—Methotrexate—hematologic cancer	9.19e-06	6.03e-05	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—PIK3CB—hematologic cancer	9.07e-06	0.000471	CbGpPWpGaD
Aciclovir—Asthenia—Methotrexate—hematologic cancer	8.95e-06	5.87e-05	CcSEcCtD
Aciclovir—Feeling abnormal—Doxorubicin—hematologic cancer	8.9e-06	5.84e-05	CcSEcCtD
Aciclovir—Nausea—Prednisone—hematologic cancer	8.87e-06	5.82e-05	CcSEcCtD
Aciclovir—Gastrointestinal pain—Doxorubicin—hematologic cancer	8.83e-06	5.8e-05	CcSEcCtD
Aciclovir—Pruritus—Methotrexate—hematologic cancer	8.83e-06	5.79e-05	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—HMMR—hematologic cancer	8.79e-06	0.000457	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—IDH2—hematologic cancer	8.79e-06	0.000457	CbGpPWpGaD
Aciclovir—Hypersensitivity—Epirubicin—hematologic cancer	8.6e-06	5.64e-05	CcSEcCtD
Aciclovir—Urticaria—Doxorubicin—hematologic cancer	8.58e-06	5.63e-05	CcSEcCtD
Aciclovir—SLC22A1—Neuronal System—MDM2—hematologic cancer	8.58e-06	0.000446	CbGpPWpGaD
Aciclovir—Body temperature increased—Doxorubicin—hematologic cancer	8.54e-06	5.6e-05	CcSEcCtD
Aciclovir—Abdominal pain—Doxorubicin—hematologic cancer	8.54e-06	5.6e-05	CcSEcCtD
Aciclovir—Diarrhoea—Methotrexate—hematologic cancer	8.54e-06	5.6e-05	CcSEcCtD
Aciclovir—Asthenia—Epirubicin—hematologic cancer	8.38e-06	5.5e-05	CcSEcCtD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.37e-06	0.000435	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ARNTL—hematologic cancer	8.27e-06	0.00043	CbGpPWpGaD
Aciclovir—Pruritus—Epirubicin—hematologic cancer	8.26e-06	5.42e-05	CcSEcCtD
Aciclovir—Dizziness—Methotrexate—hematologic cancer	8.25e-06	5.41e-05	CcSEcCtD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	8.12e-06	0.000422	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CA9—hematologic cancer	8.04e-06	0.000418	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ACP5—hematologic cancer	8.04e-06	0.000418	CbGpPWpGaD
Aciclovir—Diarrhoea—Epirubicin—hematologic cancer	7.99e-06	5.24e-05	CcSEcCtD
Aciclovir—Hypersensitivity—Doxorubicin—hematologic cancer	7.96e-06	5.22e-05	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—NCOR2—hematologic cancer	7.94e-06	0.000412	CbGpPWpGaD
Aciclovir—Vomiting—Methotrexate—hematologic cancer	7.93e-06	5.21e-05	CcSEcCtD
Aciclovir—Rash—Methotrexate—hematologic cancer	7.87e-06	5.16e-05	CcSEcCtD
Aciclovir—Dermatitis—Methotrexate—hematologic cancer	7.86e-06	5.16e-05	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—PTEN—hematologic cancer	7.84e-06	0.000407	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—ALB—hematologic cancer	7.83e-06	0.000407	CbGpPWpGaD
Aciclovir—Headache—Methotrexate—hematologic cancer	7.82e-06	5.13e-05	CcSEcCtD
Aciclovir—Asthenia—Doxorubicin—hematologic cancer	7.75e-06	5.09e-05	CcSEcCtD
Aciclovir—Dizziness—Epirubicin—hematologic cancer	7.72e-06	5.07e-05	CcSEcCtD
Aciclovir—Pruritus—Doxorubicin—hematologic cancer	7.64e-06	5.02e-05	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—IDH1—hematologic cancer	7.56e-06	0.000393	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ABCC3—hematologic cancer	7.48e-06	0.000389	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—TXN—hematologic cancer	7.48e-06	0.000389	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTO1—hematologic cancer	7.48e-06	0.000389	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—EP300—hematologic cancer	7.48e-06	0.000389	CbGpPWpGaD
Aciclovir—Vomiting—Epirubicin—hematologic cancer	7.42e-06	4.87e-05	CcSEcCtD
Aciclovir—Nausea—Methotrexate—hematologic cancer	7.41e-06	4.86e-05	CcSEcCtD
Aciclovir—Diarrhoea—Doxorubicin—hematologic cancer	7.39e-06	4.85e-05	CcSEcCtD
Aciclovir—Rash—Epirubicin—hematologic cancer	7.36e-06	4.83e-05	CcSEcCtD
Aciclovir—Dermatitis—Epirubicin—hematologic cancer	7.36e-06	4.83e-05	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—SPHK1—hematologic cancer	7.32e-06	0.00038	CbGpPWpGaD
Aciclovir—Headache—Epirubicin—hematologic cancer	7.31e-06	4.8e-05	CcSEcCtD
Aciclovir—Dizziness—Doxorubicin—hematologic cancer	7.14e-06	4.69e-05	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—UGT1A1—hematologic cancer	7.03e-06	0.000365	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.99e-06	0.000363	CbGpPWpGaD
Aciclovir—Nausea—Epirubicin—hematologic cancer	6.94e-06	4.55e-05	CcSEcCtD
Aciclovir—Vomiting—Doxorubicin—hematologic cancer	6.87e-06	4.51e-05	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—CRABP1—hematologic cancer	6.84e-06	0.000355	CbGpPWpGaD
Aciclovir—Rash—Doxorubicin—hematologic cancer	6.81e-06	4.47e-05	CcSEcCtD
Aciclovir—Dermatitis—Doxorubicin—hematologic cancer	6.81e-06	4.47e-05	CcSEcCtD
Aciclovir—Headache—Doxorubicin—hematologic cancer	6.77e-06	4.44e-05	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—ALOX5—hematologic cancer	6.66e-06	0.000346	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	6.54e-06	0.00034	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—NUP98—hematologic cancer	6.45e-06	0.000335	CbGpPWpGaD
Aciclovir—Nausea—Doxorubicin—hematologic cancer	6.42e-06	4.21e-05	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—ADCY7—hematologic cancer	6.27e-06	0.000326	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—NCOA3—hematologic cancer	6.27e-06	0.000326	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—NUP214—hematologic cancer	6.22e-06	0.000323	CbGpPWpGaD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—HRAS—hematologic cancer	6.14e-06	0.000319	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ABCG2—hematologic cancer	6.09e-06	0.000317	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—MTR—hematologic cancer	6.09e-06	0.000317	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ENO2—hematologic cancer	5.98e-06	0.000311	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTT1—hematologic cancer	5.8e-06	0.000301	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—SDC1—hematologic cancer	5.67e-06	0.000294	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PIK3CA—hematologic cancer	5.53e-06	0.000287	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.43e-06	0.000282	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.08e-06	0.000264	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CD44—hematologic cancer	4.82e-06	0.00025	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—NQO1—hematologic cancer	4.82e-06	0.00025	CbGpPWpGaD
Aciclovir—SLC22A1—Neuronal System—HRAS—hematologic cancer	4.71e-06	0.000245	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYCS—hematologic cancer	4.56e-06	0.000237	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—HSP90AA1—hematologic cancer	4.53e-06	0.000235	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—AKT1—hematologic cancer	4.52e-06	0.000235	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTP1—hematologic cancer	4.02e-06	0.000209	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ABCB1—hematologic cancer	3.8e-06	0.000198	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—NCOR1—hematologic cancer	3.69e-06	0.000192	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTM1—hematologic cancer	3.69e-06	0.000192	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—MTHFR—hematologic cancer	3.26e-06	0.00017	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PIK3CG—hematologic cancer	2.74e-06	0.000142	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CREBBP—hematologic cancer	2.54e-06	0.000132	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PIK3CD—hematologic cancer	2.41e-06	0.000125	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ALB—hematologic cancer	2.38e-06	0.000124	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PIK3R1—hematologic cancer	2.28e-06	0.000118	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PIK3CB—hematologic cancer	2.1e-06	0.000109	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PTEN—hematologic cancer	1.82e-06	9.43e-05	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—EP300—hematologic cancer	1.73e-06	9e-05	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PIK3CA—hematologic cancer	1.28e-06	6.66e-05	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—AKT1—hematologic cancer	1.05e-06	5.44e-05	CbGpPWpGaD
